NCT04628637View on ClinicalTrials.gov

High GRP78 Levels in Covid-19 Infection: A Case-Control Study

CompletedOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

April 16, 2020

Primary Completion Date

October 1, 2020

Study Completion Date

October 10, 2020

Conditions
Covid19Endoplasmic Reticulum Stress
Interventions
OTHER

Serum protein level analysis

Serum GRP78 levels of the subjects were measured through a commercially available enzyme-linked immunosorbent assay (ELISA) kit (Human Glucose Regulated Protein 78 (GRP78) ELISA Kit, Sun Long, SL2048Hu, China), as per the manufacturer's protocol. The detection rate of this kit is 16 pg/mL.

Trial Locations (1)

20070

Aylin Koseler, Denizli

All Listed Sponsors
collaborator

Pamukkale University Faculty of Medicine

UNKNOWN

collaborator

Acibadem Mehmet Ali Aydinlar University Faculty of Medicine

UNKNOWN

lead

Kafkas University

OTHER

NCT04628637 - High GRP78 Levels in Covid-19 Infection: A Case-Control Study | Biotech Hunter | Biotech Hunter